California HPV Vaccine Week



Continue to Spread Awareness!

California HPV Vaccine Week (August 4th – 10th) has ended, but you can still get out the message about the importance of the HPV vaccine as cancer prevention. The California HPV Vaccination Roundtable Parent Workgroup has compiled resources including a campaign toolkit with HPV-related cancer survivor stories, HPV facts, and a Campaign Guide with suggested social media captions and hashtags, email and newsletter content, and additional resources. If you/your organization can’t use all of the content from the Social Media Toolkit and Campaign Guide during CA HPV Vaccine Week, please feel free to use it throughout the year to help promote the importance of HPV vaccination.

use #caHPVvaxweek and #CaliforniaHPVfree

This awareness campaign was established by the California HPV Vaccination Roundtable, co-founded by CDOC and the American Cancer Society and serves as a catalyst to stimulate work on key HPV vaccination issues.

Thank for those who completed the

2024 CDOC General Member Survey!

Your input is always appreciated.

 Our winner of the $25 Amazon Gift Card is:

 Anna Knight MS, FNP-C, PHN

California Area Indian Health Service

Health Equity Workgroup Member

State Cancer Plan Revision Page

on the CDOC Website!

Revision of California's Comprehensive Cancer Control Plan, 2021-2025 is underway! California is developing a ten-year cancer plan that will include priorities and startegies to achieve by 2035. Action steps will be developed that will allow flexibility for routine revisions based on evolving evidence and emerging needs. To stay up to date with all State Cancer Plan activities, please visit the State Cancer Plan Revision page on the CDOC website.

Let Us Know How You Use

The State Cancer Plan!

Spotlight your project or a cancer control member on the CDOC member project spotlight page!



To nominate a project or an outstanding member, click here.

2021-2025 State Cancer Plan Corner

August 2024 Cancer Plan Corner Highlight

Chapter 8: Primary Prevention Chapter: Human Papilloma Virus (HPV)

Read more about the objectives and strategies for Human Papilloma Virus (HPV) vaccination on page 83 in the 2021-2025 state cancer plan. CDOC’s HPV vaccination activities are facilitated primarily through the California HPV Vaccination Roundtable. Make sure you check out the Roundtable's website to learn more about their efforts.

Please visit the CDOC website to read more on the cancer plan's Primary Prevention. You may also access the specific chapter here.

Please visit our website to read more on the cancer plan's Emerging Cancer Trends, which includes HPV associated cancers. You may also access the specific chapter here.

Contact info: cdocshare@gmail.com

August 27: Triage Cancer Webinar "Maximizing Employee Benefits" TriageCancer.org/Webinars  

Sept 9: CADCA Webinar - Clearing the Air: Steps to Going Smoke-free 

Sept 10: NCCN Webinar - 2024 Oncology Policy Summit Series

Sept 11: Prevent Cancer Foundation Webinar - Updates in Early Detection: Prostate Cancer Screening 

REGISTER BY 9/12!

Western Colorectal Cancer Consortium Conference (WC4)

The third “annual” Western CRC Consortium Conference (WC4) will be held as a hybrid event (in-person and virtual) hosted at the UC Davis Conference Center on September 26-27, 2024.

Poster Submissions (please read the submission guidance at the top of the form carefully). Click here to complete the Google Doc for your submission. If you have problems submitting via Google Docs, please contact: info@cacoloncancer.org. Poster Submission Deadline: Midnight, Sept. 6, 2024

The Upstream Research Center, co-led by Stanford, UC Davis, and UCSF, is pleased to release the third round of requests for pilot proposals. Upstream is awarding up to $75,000 each for three impact-focused research projects to reduce cancer inequities due to structural and social determinants, including, but not limited to, structural racism, poverty, income inequality, climate change, food insecurity, social isolation, and/or housing insecurity. Projects must focus on research relevant to exposures experienced in persistent poverty areas in Northern California. Read RFA and apply. Proposals are due Nov 15, 2024, at 5:00 PM PST.

Candidates are encouraged to watch the recorded information session to learn more.

The Bloodline with LLS has a new episode!

Exercise and Cancer: Celebration That You CAN

Exercise, or simply moving the body, can be an important part of cancer recovery, both physically and emotionally.

In this episode, Dr. Shernan Holtan of Roswell Park Comprehensive Cancer Center and blood cancer survivors, Paul Rothweiler and Joe Grey, share about a clinical trial they developed to introduce a personalized strength training program to patients and caregivers.

Dr. Holtan highlights the benefits of strength training for all patients, while Paul and Joe share how exercise has aided their physical and emotional recovery during and after their treatments.

For patients and survivors who may be fearful or nervous about starting an exercise program, this episode is for you! Please note, it is important to talk to your doctor before starting an exercise program

Our partners at the GW Cancer Center also have a HPV awareness toolkit to implement evidence-based practices when communicating about HPV vaccinations for children, adolescents, and young adults. Visit the GW Cancer Control TAP website to learn more.

We need your help to change the future of cancer as we know it. Support our goal of reaching 100,000 Black women for VOICES of Black Women, a pivotal long-term study led by the American Cancer Society (ACS). This groundbreaking initiative will help us better understand health conditions like cancer to learn how to improve overall health and well-being among Black women. ACS is looking to mobilize local partners to share the study with their networks.

If you are interested in learning more about how you or your organization can support VOICES, please reach out to bridget.freeley@cancer.org for or if you have questions about the study, you can also contact thevoices@cancer.org.

Prevent Cancer. Cancer Prevention Works Summer 2024 issue is out now! In the latest edition of Cancer Prevention Works, you'll learn exactly what a skin check entails, what you need to know about skin cancer if you have a darker skin tone, alcohol's role in increasing cancer risk and key updates from the Hill on cancer prevention legislation. Explore this and more in your Summer issue. Read here.

The UCSF Helen Diller Family Comprehensive Cancer Center and The California Prostate Cancer Coalition (CPCC) co-hosted the 4th Annual Patient Conference on Prostate Cancer at the UCSF Medical Center at Mission Bay. A stellar faculty, including Eric Small, MD; Peter Carroll, MD, MPH; Matt Cooperberg, MD, MPH; Mack Roach III, MD; June Chan, ScD; Rahul Aggarwal, MD; and Thomas Hope, MD, presented at the conference. View the event recording here.

CANServ: Revolutionizing Cancer Patient Care Challenge (Due Aug 28)

Funding Opportunity: Leukemia & Lymphoma Society Building Evidence for Effective Interventions to Increase Therapeutic Cancer Clinical Trial Accrual: Promoting Access for Patients from Underrepresented Groups (Due Sep 12)

Funding Opportunity: Robert Wood Johnson Foundation Evidence for Action: Innovative Research to Advance Racial Equity (Open Until Filled)

The Leukemia & Lymphoma Society (LLS) - support resources available. Visit their website to learn more click here

Assessment Instruments for Measuring Community Engagement Validated instruments to assess meaningful community engagement including Trust. To learn more click here. 

National Behavioral Health Network (NBHN) - Their newly released resource titled, Addressing Disparities and Increasing the Quality of Tobacco Treatment for African Americans is now available. This brief infographic highlights the increased risk for tobacco exposure and use, emphasizing mentholated cigarettes, among the Black and African American community, and offers 6 equity-driven approaches to addressing this disparity.

The President’s Cancer Panel’s Initial Assessment of the #NationalCancerPlan is now available! Informed by stakeholder activities happening across the cancer community, the report highlights recommendations in five priority areas to accelerate progress toward the National Cancer Plan goals. Learn more about the challenges and opportunities identified by the Panel to ensure that every person in the United States has access to the best possible resources and care for cancer risk reduction, detection, treatment, and survivorship, Read more here.



Read about the National Cancer Plan! We know that our continued progress against cancer is the direct result of advances made possible by investment from federal, state, and local governments, along with private investment, and by the sustained efforts of researchers around the world and millions of people with cancer, their caregivers, and advocates. Read more about the National Cancer Plan here.

Cancer affects everyone, but it does not affect everyone equally. LGBTQ+ individuals face unique obstacles in accessing health care, leading to disparities in cancer prevention and treatment. Explore the resources on the Prevent Cancer Foundation Website to find information on cancer screenings, tools to talk to your health care providers and much more.  

Fact Sheet: ACS Cancer in People who Identify as Lesbian, Gay, Bisexual, Transgender, Queer, or Gender Non-conforming

Dr. Mandi Pratt-Chapman Advances Work on Sexual Orientation and Gender Identity Data in Cancer Continuum Mandi Pratt-Chapman, PhD, Associate Director, Community Outreach & Engagement, has co-authored a paper in the American Society of Clinical Oncology Journal on the significance of SOGI data in cancer research. She also gave an interview with The American Journal of Managed Care, which highlights factors affecting adequate, accessible health care for transgender patients and what she sees as the most pressing need to address in this community, and explores the potential for policy-level changes to benefit transgender patient care and experiences in clinical settings.

City of Hope – The California Cancer Care Equity Act (CCCEA) The California Cancer Care Equity Act (SB 987, Chapter #608, 2022), which took effect January 1, 2023, expands access to optimal cancer care for historically disadvantaged Californians by requiring Medi-Cal managed care plans (MCMCPs) to make a good faith effort to contract with National Cancer Institute-designated and other specified cancer centers so that patients with a complex cancer diagnosis may more easily access care at these centers. The law also authorizes Medi-Cal members diagnosed with a complex cancer to request a referral to any of those centers and requires MCMCP to notify all members of their right to do so. You may read more about it here.

NEW! NATIONAL CANCER INSTITUTE (NCI). “FDA Approves HPV Tests That Allow for Self-Collection in a Health Care Setting.” On May 14, the Food and Drug Administration (FDA) expanded the approvals of two tests that detect cancer-causing types of human papillomavirus (HPV) in the cervix. Both tests are used as part of screening for cervical cancer. Under these expanded approvals, people can now be offered the option to collect a vaginal sample themselves for HPV testing if they cannot have or do not want a pelvic exam. However, the collection, which involves a swab or brush, must be done in a health care setting, such as primary care offices, urgent care, pharmacies, and mobile clinics. The tests included in the approvals are Onclarity HPV, made by Becton, Dickinson and Company (BD), and cobas HPV, made by Roche Molecular Systems. Read more here.

NEW! CDC's PREVENTING CHRONIC DISEASE. “State and Regional Trends in Incidence and Early Detection of Lung Cancer Among US Adults, 2010–2020.” Lung cancer is the leading cause of cancer death in both male and female adults in the US. Overall incidence rates of lung cancer continue to decline following historical declines in cigarette smoking, estimated to account for roughly 90% of lung cancer cases. However, disparities in incidence persist among certain racial and ethnic groups and between sexes. For example, recent reports have shown rates remaining stable among female non-Hispanic Asian and Pacific Islander (NH-API) people and female non-Hispanic American Indian or Alaska Native (NH-AIAN) people. State and regional trends in lung cancer incidence and the proportion of cases diagnosed at localized-only stage have not been recently described. This study measured geographic trends in incidence and the proportion of new cases diagnosed at localized-only stage, among male and female adults and by race and ethnicity, from 2010 through 2019. Read more here.

Prevent Cancer. “Historic bipartisan cancer prevention legislation passes unanimously in the House Ways and Means Committee.” On June 27, The Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 2407) was marked up and passed by the House Ways and Means Committee by a unanimous, bipartisan vote of 38-0. As of July 12, the legislation is supported by more than 290 cosponsors in the House of Representatives and more than 60 in the Senate--the most support the bill has seen since its introduction to Congress--representing a substantial majority and strong bipartisan support. This legislation also has the support of more than 500 leading health care and advocacy organizations across the U.S., demonstrating the significant impact that it would have on a diverse set of communities throughout our nation. Passage out of committee is an important and crucial step in the legislative process. Now, the bill needs to move onto the House floor, be passed by both chambers of Congress and signed into law.  Today, there are recommended routine screenings for only a few of more than 200 cancers, leaving most cancers undetected until symptoms appear, often in later stages. This legislation responds to the misalignment between advances in science and outdated policy. If passed, Medicare beneficiaries will have the possibility of access to multi-cancer early detection (MCED) tests once they are approved by the Food and Drug Administration (FDA) and shown to have clinical benefit. MCED tests, also called liquid biopsies, are blood-based tests designed to identify the presence of cancer for more than one cancer at a time.  

CMS Newsroom. Expanding Preventive Services: Hepatitis B Vaccinations, Drugs Covered as Additional Preventive Services, and Colorectal Cancer Screenings CMS is proposing to expand coverage of the hepatitis B vaccine for people with Medicare who have not received the hepatitis B vaccine or whose vaccination status is unknown, with no cost to the individual. We are also proposing to allow people with Medicare to get the hepatitis B vaccine from pharmacies and to allow pharmacies and mass immunizers to roster bill Medicare consistent with current billing for flu, pneumococcal, and COVID-19 vaccines. CMS is also proposing to update and expand coverage of colorectal cancer screening to promote access and remove barriers for much needed cancer prevention and early detection, that may be especially important within rural communities and communities of color. Read more here

CMS Newsroom. CMS proposes for Medicare to pay an add-on to the AIR for high-cost drugs and biologics that significantly exceed the AIR. Addressing equity and access barriers is a critical part of the Biden Administration’s Cancer Moonshot, which the President and First Lady reignited as a national effort to prevent more than 4 million cancer deaths by 2047 and improve the experience of people who are touched by cancer. With this proposed rule, the Biden-Harris Administration is taking a significant step to support IHS and Tribal facilities in providing cancer care, and, importantly, establish a pathway for Tribal facilities seeking to expand the breadth of health care services, including oncology, that they provide to their communities to decrease health inequities and improve outcomes for those facing cancer. Read more here.

CDOC is made up of a diverse group of stakeholders that engage in important and impactful work we'd like to showcase. We have a new process for submitting your trainings, events, articles, grant opportunities, and more.  

We kindly ask you to email us any content by the 15th of each month to cdocshare@gmail.com. If there is time-sensitive information (e.g. upcoming training) that you would like to share, we will do our best to include, but cannot guarantee that it will make the newsletter or announcements.  

Submission requirements: 

• Include a title
• Include the exact verbiage you'd like for us to include. Please do not include an attachment and ask us to share, a title and verbiage must be included.
• Include a contact person for any inquiries   
• Include any attachments in a pdf file if possible

We appreciate your patience and support at this time, and we look forward to your submissions.